St. Jude Medical paid about $123 million to acquire a developer of small, leadless cardiac pacemakers not yet approved in the U.S. The deal follows St. Jude's 2011 recall of leads for two of its pacemakers.
The deal with Nanostim, an early-stage medical-device company based in Milpitas, Calif., has been in the works for several years.
Read more »
Mount Sinai Hospital CEO Dr. Kenneth Davis reportedly sees no antitrust bumps on his organization's path to absorbing Continuum Health Partners into what would be New York City's largest healthcare provider.
The Mount Sinai and Continuum boards just this week signed a definitive agreement. Davis, as paraphrased in the New York Times, said a regional office of the Federal Trade Commission had already given them the all-clear.
Read more »
Eye-care firms continue to be a hot target this year as pharmaceutical and medical-device firms see a growing market for ophthalmology procedures.
Abbott Laboratories, the Illinois-based medical-device giant, is shelling out $250 million for OptiMedica Corp., which makes technology for laser-assisted cataract surgery.
Read more »
Watch out, community hospitals. The proposed merger between Tenet Healthcare Corp. and Vanguard Health Systems is expected to increase pressure on already-struggling stand-alone facilities in the markets where the two chains operate.
While the deals, Moody's Investors Service says the combination of two “large and powerful systems” will be a force to be reckoned with. In particular, Tenet will have more leverage to lure physicians away from smaller hospitals and will be able to take advantage of back-office economies of scale that will help reduce costs at a time of shrinking reimbursement and increased pressure on volumes.
Read more »
